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Abstract
Introduction: Risk factor analyses for nosocomial infections (NIs) are complex. First, due to competing events
for NI, the association between risk factors of NI as measured using hazard rates may not coincide with the
association using cumulative probability (risk). Second, patients from the same intensive care unit (ICU) who
share the same environmental exposure are likely to be more similar with regard to risk factors predisposing to a
NI than patients from dierent ICUs. We aimed to develop an analytical approach to account for both features
and to use it to evaluate associations between patient- and ICU-level characteristics with both rate of NI and
competing risks and with the cumulative probability of infection.
Methods: We considered data from a multi-center cohort study including 159 intensive care units containing
109202 admissions (710221 admission-days) from the Spanish HELICS-ENVIN ICU network. We analysed the
data using two models: etiologic model (rate-based) vs a predictive model (risk-based). In both models, random
eects (shared frailties) are introduced to assess heterogeneity. Death and discharge without NI are treated as
competing events for NI.
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Results: We observed a large heterogeneity across ICUs in NI hazard rates which still remained after accounting
for multilevel risk factors meaning that there are remaining unobserved ICU-specic factors which inuence NI
occurrence. Heterogeneity across ICUs in terms of cumulative probability of NI was even more pronounced.
Several risk factors had markedly dierent associations in the rate-based and risk-based models. For some the
associations diered in magnitude: number of beds in ICU, trauma, APACHE II score. Others diered in sign:
both respiratory and central nervous system versus cardiovascular diagnoses.
Conclusions: A combination of competing risks and multilevel models is required to understand direct and
indirect risk factors for NI and distinguish patient-level from ICU-level factors.
Keywords: hospital epidemiology, shared frailty model, random eects, clustered data, hierarchical data,
residual confounding, modelling infectious diseases
Introduction
Nosocomial infections (NI) are considered to be a major threat for hospitalized patients, particular in
intensive care units (ICUs) because they are associated with an increased mortality and morbidity [1, 2].
Analysis of data from large multicentre studies has the potential to improve our understanding of how
patient and ICU-level characteristics impact on NI outcomes. Such analysis, is however, complicated by
two factors: unexplained ICU-level variation and the importance of competing risks.
First, there are endogenous and exogenous modes of NI acquisition [3]. Harbarth et al. [3] showed that
about 20% of NIs are exogenous and therefore potentially preventable. Potential transmission routes of
exogenous NIs are contaminated environment or cross-transmission via health-care workers or patients.
Thus, patients from the same intensive care unit (ICU) who share the same environmental exposure are
likely to be more similar with regard to acquiring a NI than patients from dierent ICUs. In addition to
patient-individual characteristics, ICU-specic factors such as number of beds and nurses, type of ICU,
infection control policies are potential determinants for the occurrence of NI.
To distinguish patient-level and ICU-specic factors requires multilevel analysis, but this is rarely used in
hospital epidemiology [4]. The clustered structure of the data (patients within ICUs) often contains
information that can be of value in understanding associations between risks and NIs [5].
Second, the length of ICU stay is a key determinant of the risk of NI. However, most patients are
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discharged from ICU or die in ICU without NI; factors which are associated with a high increased rate of
infection are often also associated with an increased risk of dying in the hospital as well as with an
extended length of stay. These competing events play an important role in risk interpretation of NI and
make extended survival models necessary [6{9]. Again, rates of NI, discharge and death without NI might
also depend on patient- as well as on ICU-level factors. Thus, a combination of extended survival and
multi-level models is required to understand how dierent risk factors impact on NI outcomes.
The aim of this paper is to apply established and innovative methodology [10,11] to investigate
heterogeneity across ICUs in risks and rates of NI and concurrently occuring competing events.
Methods
Spanish ICU data
We used a multi-center cohort study from the Spanish surveillance network HELICS-ENVIN
(http://hws.vhebron.net/envin-helics/), embedded in the HELICS project (Hospitals in Europe Link for
Infection Control through Surveillance). The reliability and quality of the surveillance program has
recently been conrmed [12]. Data are collected on individual patient level and also aggregate ICU level.
For our purpose, we included only patients who were admitted to ICU between January 2006 and
December 2011 and stayed at least two days in ICU. We excluded ICUs which contributed less than 100
patient admissions to the cohort to reduce heterogeneity from very small ICUs. In order to have a robust
outcome, we focused on primary or secundary nosocomial bacteremia (NB). The study population, 159
intensive care units containing 109202 admissions (710221 admission-days), is summarized in table 1.
Shared frailty models for competing risks
Model 1: Etiologic Model (rate-based)
The classical way to analyze competing risks data is to study event-specic hazard rates, i.e., tting a
proportional hazard model for each event (NB, death without NB, discharge without NB) separately.
Random eects for each ICU (i.e. frailties) can be introduced by a shared gamma frailty model [10,13] (see
details in appendix). For each of the three events (NB, death, discharge), we tted such a model to assess
heterogeneity for NB rates, quantied by the corresponding variance estimator . Large variances signify a
closer similarity between patients within ICU and greater heterogeneity across ICUs. Following quantities
are calculated for each of the three events: the baseline hazard, ICU eects, variance of ICU eects () and
the hazard ratios for multilevel risk factors.
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Model 2: Predictive Model (risk-based)
The cumulative incidence function of NB is dened as the probability of NB over a period of time and
interpreted as the actual risk of NB occurring in this time period. This approach is useful for predicting
NB. It has previously been shown that the way in which risk factors are associated with the NB hazard
may not coincide with the way these factors are associated with the cumulative incidence of NB [14]. To
study the risk (cumulative incidence function) of NB, we used the Fine and Gray model [15] and
introduced a shared frailty structure to investigate heterogeneity in a similar way as Katsahian et al [11].
Using this model we calculated the following quantities: the baseline subdistribution hazard and
corresponding cumulative incidence of NB, ICU eects, variance of ICU eects () and the subdistribution
hazard ratios for multilevel risk factors.
For both models, we rst used a model with frailties for each ICU but without covariates (null model).
Then, we considered a multivariate model by introducing patient-individual as well as ICU-specic
covariates and estimated the frailties for each ICU. For all analyses we used the exible R-package
frailtyPack [16].
Results
The study population is described in table 1.
In the following we present the detailed results for primary or secundary nosocomial bacteremia (NB).
Baseline hazard rates
Based on the null models without covariates, the overall baseline hazard rates for each event are shown in
Figure 1. The hazard rate of NB steadily increased with the time from admission; for instance, the daily
risk of acquiring a NB at day 10 (day 30) for a patient is about 1% (1.5%) given that he or she has stayed
at ICU without a NB for at least 9 days (29 days). The death hazard rate without NB is about 2% for the
rst 40 days from admission. Obviously, the discharge hazard rate without NB is the strongest hazard with
its peak (about 25%) about 5-6 days after admission and a strong decrease afterwards; meaning the
likelihood of discharge without NB decreases for each survived day in ICU.
Heterogeneity across ICUs
The corresponding ICU eects (random eects or frailties) of the null models are in Figure 2; for instance,
an ICU eect of 2 means that the baseline hazard of this ICU is twice as large as the hazard averaged over
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all ICUs. The observed heterogeneity across ICUs in rates of NB is remarkably large (=0.26 with
SE=0.038), in contrast to the death (=0.14 with SE=0.019) or discharge (=0.15 with SE=0.017) rates
without NB. The heterogeneity in risks of NB is even larger than in rates (estimated by =0.64 with
SE=0.076). Large heterogeneity means that event times are strongly correlated within ICUs. One might
conclude that observed and unobserved ICU-specic factors play a more substantial role in the NB hazard
rates compared to the competing event rates.
Including covariates in the models led to only a small reduction in ICU-level heterogeneities for all three of
the competing outcomes, with  falling to 0.5 for NI, still more than twice as large as heterogeneities in
rates of the competing events (table 2). Separate models (only ICU-level factors and only patient-level
factors) showed that ICU-levels contributed to more reduction than the patient-level factors (table 2). It
follows that the impact of unobserved ICU-specic factors is large. The reduction is stronger in the NB
risk than the NB rate model. There are patient-level factors such the APACHE II score, type of diagnosis
or trauma (table 2) which have a strong eect in reducing the discharge without NB hazard (the strongest
competing risk hazard), i.e., patients with high APACHE II scores or trauma stay longer in ICU. There are
also ICU-level factors which are more pronounced: number of beds in ICU and teaching hospital. Thus,
there is an indirect eect on the risk on NB leading to increased subdistribution hazard ratios. And strong
eects lead to a reduction in heterogeneity.
Multilevel risk factors: patient-level
Results from the risk factor analysis on the patient as well as ICU level are shown in table 2. The hazard
ratios for NB from the event-specic analysis (model 1) reect direct eects on the occurrence of NB; this
event-specic approach also shows how these factors are associated with the competing events, i.e., which
potentially indirect eects on NB. The subdistribution analysis (model 2) is a summary analysis and
studies the eects on the risk (cumulative incidence function) of NB. Factors with a hazard ratio lower
than 1 on the competing events increase the risk of NB. Otherwise, factors with a hazard ratio greater than
1 on the competing events decrease the risk of NB. Often, the hazard ratios for discharge and death
without NB are diametrically opposed; then, the discharge hazard has usually a stronger indirect eect
because of its larger magnitude compared to the death hazard (gure 1). For instance, the APACHE II
score is highly associated with an increased rate of NB but also highly associated with an increased death
(without NB) rate and a decreased discharge (without NB) rate (i.e., with a longer ICU stay). The indirect
eect due to an extended length of ICU stay make patients with higher APACHE II score acquire an NB
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more frequently, which is quantied by the subdistribution hazard ratios. It is even possible that a hazard
ratio for NB is lower than 1 but the subdistribution hazard ratio is larger than 1 (such as respiratory vs.
cardiovascular diagnosis). These results highlight just some the complexities of examining risk factors of NI
in the presence of competing risks.
Multilevel risk factors: ICU level
A larger number of beds in ICU was somewhat associated with an increased rate of NB (table 2). This
association also remained in the subdistribution model because the number of beds in ICU are only
moderately associated with the competing events. The rate of NB is higher in university/teaching hospitals
compared to those without teaching; an eect which has also been found elsewhere [17]. This eect is even
more pronounced in the subdistribution model because patients in hospitals without teaching are
discharged quicker.
Discussion
In this paper, we used two multilevel competing risks models to evaluate risk factors of NI. To our
knowledge, this is the rst study which investigates the heterogeneity across ICUs in risks and rates of NI
using a large multi-center cohort accounting for both ICU clustering eects and competing risks. Further,
we showed that it is necessary to perform a multilevel competing risk analysis to fully understand the
direct and indirect eect of risk factors on the occurrence of NI.
Our ndings have the following implications. First, the large heterogeneity indicates that the impact of
unobserved ICU-specic factors (also known as residual confounding) on the risk and rate of NI is large,
even after accounting for important patient and observed ICU level characteristics. Thus, surveillance
networks are encouraged to collect further potential ICU-level risk factors in addition to patient-level data.
This large heterogeneity might also explain why ICU-based infection control strategies might work in some
ICUs but not in others. It emphasizes the need for multi-center intervention studies rather than
single-center pilot studies [18,19]. Ignoring heterogeneity in the analysis of multi-center studies can lead to
biased results and misleading conclusions.
In our cohort, risks of NI were more heterogeneous than rates of NI across ICUs. From the mathematical
point of view, this is not necessarily the case since dierent correlations between competing hazards
constellations could potentially result in a very similar risk of NI.
Second, competing risks play an essential role in the understanding of NI occurrence and the analysis must
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account for this [7]. The distinction between indirect and direct eects are key issues for understanding the
associations between risk factors and NI outcomes. We recommend that the results from both models (the
rate and the risk model) are reported [20]. This is very important for NI since risk factors for NI are often
also associated with the competing risks for NI as well. This may result in more pronounced eects in the
risk model (such as APACHE II score, type of diagnosis or trauma) or eects which are relevant only in
the rate model but irrelevant in the risk model (antibiotic treatment before ICU admission). It could even
lead to apparent diametrically opposed results (both respiratory and central nervous system versus
cardiovascular diagnoses). Third, our approach has the potential to identify ICUs with unusually high or
low rates. Nevertheless, we emphasize that extreme caution is needed by using NI rates or risks for
benchmarking or as quality indicators. Beside problems in reliability, validity [21] and statistical
uncertainty, it is further complicated by competing risks as shown here.
There are some limitations to our study. As in other large surveillance studies, data can be subject to
reporting or information bias. Therefore, it is possible that part of the heterogeneity might be attributed
to over- or underreporting of NI rather than to real ICU factors [22]. As suggested by Hansen et al. [17],
surveillance data need to be validated to counter dierences across ICUs.
Multilevel analyses in hospital infection epidemiology are still rare but necessary to evaluate eects of
individual-level and group-level factors [4]. Vellinga have produced a valuable overview of the principles of
multilevel analysis for antimicrobial resistance studies [5]. We have extended their methodology to complex
survival data of hospital infections because modeling the timing of events (infection, death, discharge) is
crucial. We encourage further investigations by using our methodological approaches, e.g., to evaluate the
occurrence of antimicrobial resistance by exploring antibiotic usage on patient-level and ICU-level
simultaneously. Statistical models and corresponding codes are available in the appendix.
Key messages
 Discharge from and death at the intensive care unit are competing risks for nosocomial infection.
 There are factors on the patient as well as on the ICU level inuencing the occurrence of nosocomial
infections.
 Analysis of data from large multicentre studies has the potential to improve our understanding of
how patient and ICU-level characteristics impact on nosocomial infections.
 A combination of multilevel and competing risk models are necessary to analyse such complex data.
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 We encourage further investigations by using our methodological approaches, statistical code is
available in the appendix.
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Figure 1: Estimated baseline hazard functions and associated 95% CIs (broken line) from the null model
without covariates, for each of the three outcomes.
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Figure 2: Estimated frailties (random eects) for each ICU from the null model without covariates, for each
of the three outcomes. The ICUs are ordered on the X-axis according to the contributing number of patients;
circles are proportional to the magnitude of contribution of the ICU, e.g., an ICU with sqrt(Npatients)=60
contributed 602 = 3600 admissions to the cohort. The Y-axis is on a log scale.
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Figure 3: Estimated hazard function (left) and cumulative incidence function (right) from the shared frailty
model for the subdistribution hazard of NI without covariates (black curves) and associated 95% CIs (broken
line).
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Figure 4: Estimated frailties (random eects) for each ICU from the shared frailty model for the subdistri-
bution hazard of NB without covariates. The ICUs are ordered on the X-axis according to the contributing
number of patients; circles are proportional to the magnitude of contribution of the ICU, e.g., an ICU with
sqrt(Npatients)=60 contributed 602 = 3600 admissions to the cohort. The Y-axis is on a log scale.
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